The effect of methanol extract of Lippia citrodoria in the prevention and control of IBD induced by acetic acid in mice

Subject Areas : Developmental biology of plants and animals , development and differentiation in microorganisms

maryam teimouri ¹ (Department of Biology, Roudehen Branch, Islamic Azad University, Roudehen, Iran)
Fariba Khosravinejad ² (Department of Biology, Faculty of Science, Islamic Azad University, Tehran North branch, Tehran, Iran.)

Received: 2018-07-17 Accepted : 2018-09-22 Published : 2018-12-11

Keywords: Lipid peroxidation, Mice, inflammatory bowel disease, Lippia citrodoria,

Abstract :

Inflammatory bowel disease (IBD) is a chronic condition of the intestine with unknown etiology involving multiple immune, genetic and environmental factors. We were interested to examine the effect of extract from Lippia citrodoria, a medicine plant in prevention and control of experimental mouse IBD. L.citrodoria was administered (50, 150.200 mg/kg) through drinking water to IBD mice (induced by intrarectal administration of acid-induced). Prednisolone was used as the standard drug for comparison. Biochemical, macroscopic and microscopic examination of colon were performed. Biochemical evaluation of inflamed colon was done using assay of myeloperoxidase (MPO) activity and thiobarbituric acid reaction substances(TBARS) concentration as indicators of free radical activity and cells lipid peroxidation. Results indicated that the activity of MPO and lipid peroxidation products (TBARS) increased in acetic acid-treated group while recovered by pretreatment of animals with L.citrodoria (50,150,200 mg/kg) and prednisolone. L.citrodoria (50-100mg/kg) and prednisolone. L.citrodoria (50-200 mg/kg) and prednisolone-treated groups showed significantly lower score values of macroscopic and microscopic characters when compared to the acetic acid – treated group. The benefical effect of L.citrodoria ( 200mg/kg) was comparable to that of prednisolone.It is concludes that the antioxidant, antimicrobial, and anti-inflammatory potentials of L.citrodoria might be the mechanisms by which this extract protects animals against experimentally induced IBD. Proper clinical investigation should be carried out to confirm the activity in human

References:

[1]      Abdollahi M. 2003, Increasing intracellular CAMP and CGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva. Comparative Biochemistry and Physiology Part C Toxicology Pharmacology,135, 331-336.

[2]      Abdollahi M, Chan TS, Subrahmanyam V, O'Brien PJ. 2003, Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte CAMP levels, glycogenolysis, glu mistery,252: 205-211.

[3]      Abdollahi M., Ranjbar A., Shadnia S., Nikfar S., Rezaiee A. 2004, Pesticides and oxidative stress. Medical Science Monitor Review 10: RA144-RA147.

[4]      Aghababaeian R. 2005, Protective effects of sildenafil and dipyridamol from lead-inducedlipid peroxidation in perfused rat liver. International Journal of Pharmacology, 1: 157-160.

[5]      Ahnfelt-Ronne I, Nielsen OH. The antiinflammatory moiety of sulfasalazine, 5aminosalicylic acid, is a radical scavenger. Agent and Actions. 1987; 21: 191-194.

[6]      Arnhold J. 2004, Properties, functions, and secretion of human Biochemistry. Myeloperoxidase, 69: 4-9.

[7]      Arnhold J. 2004, Properties, functions, and secretion of human myeloperoxidase. 69(1); 4-9.

[8]      Argyropoula C, Daferera D, Trantilis PA, Fasseas C, Plassiou M. 2007, Chemical composition of the essential oil from leave of Lippia citrodoria H.B.K. Biochemical systematic and Ecology,35: 831-837.

[9]    Barbosa DS, Ce cchini R, E 1, Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplement with fish oil omega-3 fatty acids. Nutrition journal. 2003; 19: 837-842.

[10] Barbosa FG, Lima MAS, Silveira ER. 2015, Total NMR assignments of new bifala vonrs from leaves of the Limonene carvon chemotype of Lippia alba (Mill) N.E. Brown. Magnetic respond of Chemistry, 4: 334-338.

[11]   Choupani M, Arabshahi Delouee S, Alami M. .2014, Antioxidant Properties of Various Solvent Extracts of Lemon Verbena (Lippia citriodora) Leaves. International journal of Advanced Biological and Biomedical Research effects of aethiop,2: 1340-1346.

[12]   Constantin M, Dabire, Remy K, Bationo, Adama Hema, Roger C. H, Nebie, Eloi Pale S. P. . 2015, Dhanabal3 and Mouhoussine Nacro, Total phenolics content, flavonoids profiling and antioxidant activity of Lippia multiflora leaves extracts from Burkina Faso. Asian Journal of Plant Science and Research, 5:28-33.

[13]   Cowan MM .1999, Plant products as antimicrobial agent. Clinical Reviews, 12(4): 564-582.

[14]   D'O2dorico A., Bortolan S., Cardin R, D'Inca' R, Martines D, Ferronato A, Sturniolo GC. 2001, Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 36: 1289-1294.

[15]   Elson CO, Sartor RB, Tennyson GS, Riddell RH.1995, Experimental models of inflammatory bowel disease. Gastroenterology,109: 1344-1367.

[16]   Hadjibabaie M., RastkariN., Rezaie A., Abdollahi, M.2005, The adverse drug reaction in the gastrointestinal tract: an overview. International Journal of Pharmacology, 1: 1-8.

[17]   Henebelle T, Sahpaz S, Dermant H, Joseph H. 2006, The essential oil of Lippia alba
analysis of sample from French overseas department of review. Chemistry of Biodiversity, 3: 1116-1125.

[18]   Hirayama A, Nagase S, Ueda A, Ishizu T, Taru Y, Yoh K, Hirayama K, Kobayashi M, Koyama A. 2003. Oxidative stress during leukocyte absorption apheresis. Journal of clinical Apheresis; 18: 61-66.

[19]   Hong T, Jin GB, Cho S, Cyong JC. 2002, Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Medica,68: 268-271.

[20]   Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M .2004. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Digestive Diseases and Sciences; 49: 1752-1757.

[21]   Jurjus AR, Khoury NN, Reimund JM. 2004, Animal models of inflammatory bowel disease. Journal of Pharmacology and Toxicology Methods,50: 81-92. 

[22]   Jurjus AR, Khoury NN, Reimund JM. 2013, Animal models of inflammatory bowel disease. Journal of Pharmacology and Toxicology Methods, 50: 81-92.

[23]   Kanof ME, Lake AM, Bayless TM. 1988, Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology,95: 1523–1527.

[24]   Kirsner JB, Shorter R.1982, Recent developments in "non-specific" inflammatory bowel disease. New England Journal of Medicine,306: 775–785.

[25]   Kvietys PR, Inauen W., Bacon BR, Grisham MB. 1989, Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical. Am J Physiol,257: 1640-1646.

[26]   Kvietys PR, Inauen W, Bacon BR, Grisham MB. 1989, Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical. American Journal of Physiology, 257(5);1640-1646.

[27]   Lih-Brody L., Powell SR., Collier KP., Reddy GM., Cerchia R., Kahn E., Weissman G.S, Katz S., Floyd RA., McKinley MJ., Fisher SE., Mullin GE. 1996, Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digestive Diseases and Sciences journal, 41: 2078-2086.

[28]   MacPherson B, Pfeiffer CJ. 1976, Experimental colitis. Digestion.,14: 424-452.

[29]   Nakamora T, Okuyama E, Tsukada A, Yamazaki M, Satake M, Nishibe S, Deyama T, Moriya A, Maruno M, Nishimora H. 1997, Acteoside as the analgesic principle of cedron (Lippia triphylla) a Peruvian medical plant. Chemical   pharmaceutical Bullentin, 45: 499-504.

[30]   Rezaie A., Taghavi B., Abdollahi M.2005, Biologic Management of fistulizing Crohn's disease. International Journal of Pharmacology, 1(1);17-24.

[31]   Saiki T. .1998. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease, Kurume Medical Journal, 45: 69-73.

[32]   Sanchez de Medina F., Vera B., Galvez. J, Zarzuelo A. 2002, Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Science. 70, 3097-3108.

[33]   Sartoratto A, Mashado ALM, Delarmelina C, Figueira GM, Duarte MCT, Rehder VLG.2004, Composition and antimicrobial activity of essential oil from aromatic plants used in Brezil. Brazilian Journal of Microbiology, 34(4): 1517-1520.

[34]   Schempp H., Toth A., Weiser D., Elstner EF. 2003, Antioxidative properties of Iberis amaraextracts in biochemical model reactions. Arzneimittelforschung ,53(8): 568-577.

[35]   seddigh J, Maftoon F, Ziaie G. 2004, Herbal medicine, attitude in population of Tehran city. Medical plants, 4(14): 60-67.

[36]   Sharon P, Stenson WF. 1985, Metabolism of arachidonic acid in acetic acid colitis in rats. Gastroenteroloogy, 88: 55-63.

[37]   Şimmonds NJ., Rampton DS.1993, Inflammatory bowel disease-a radical view. Gut journal; 34: 865-368

[38]   Simmonds NJ, Millar AD, Blake DR, Rampton DS.1999, Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell free systems and inflamed human colorectal biopsies. Alimentary Pharmacology and Therapeutics,13: 363-372.

[39]   smet P. 2005, Herbal medicine in Europe relaxing regulatory standards. New England Journal of Medicine, 35: 54-5.

[40]   Tuzun A., Erdil A., Inal V., Aydin A., Bagci S., Yesilova Z., Sayal A., Karaeren N., Dagalp K. 2000 ress and antioxidant capacity in patients with inflammatory bowel disease. Clinical Biochemistry, 35: 569-572.

[41]   Vasiliauskas EA.1999, An open label pilot study of low dose thalidomide in chronically active, steroid dependent Crohn's disease. Gastroenterology,117: 1278–1287.

[42]   Yamada T, Marschall S, Specian RD, Grisham MB. 1991, A comparative analysis of two models of colitis in rats. Gastroenterology,102: 1524-1534.